Prolixin



Indications and Reactions:

Role Indications Reactions
Primary
Delusion 14.3%
Schizophrenia 14.3%
Depression 11.4%
Psychotic Disorder 11.4%
Anger 8.6%
Schizoaffective Disorder 8.6%
Bipolar Disorder 5.7%
Drug Prescribing Error 5.7%
Alcohol Detoxification 2.9%
Back Pain 2.9%
Mental Disorder 2.9%
Paranoia 2.9%
Post-traumatic Stress Disorder 2.9%
Schizoaffective Disorder Bipolar Type 2.9%
Schizophrenia, Paranoid Type 2.9%
Neuroleptic Malignant Syndrome 11.5%
Memory Impairment 7.7%
Suicidal Ideation 7.7%
Tremor 7.7%
Weight Increased 7.7%
Aggression 3.8%
Blood Pressure Abnormal 3.8%
Delusion 3.8%
Drug Hypersensitivity 3.8%
Drug Ineffective 3.8%
Feeling Cold 3.8%
Movement Disorder 3.8%
Musculoskeletal Stiffness 3.8%
Myalgia 3.8%
No Adverse Event 3.8%
Pain In Jaw 3.8%
Parkinsonism 3.8%
Pituitary Tumour 3.8%
Pituitary Tumour Benign 3.8%
Posturing 3.8%
Secondary
Schizophrenia 17.4%
Anxiety 12.9%
Depression 12.9%
Product Used For Unknown Indication 10.7%
Mental Disorder 7.3%
Anxiety Disorder 5.6%
Bipolar Disorder 3.9%
Agitation 3.4%
Insomnia 3.4%
Psychotic Disorder 3.4%
Sedation 3.4%
Convulsion 2.2%
Drug Use For Unknown Indication 2.2%
Schizoaffective Disorder 2.2%
Extrapyramidal Disorder 1.7%
Headache 1.7%
Hypersensitivity 1.7%
Ill-defined Disorder 1.7%
Dysphonia 1.1%
Hypertension 1.1%
Dizziness 15.0%
Dysuria 7.5%
Neuroleptic Malignant Syndrome 7.5%
Somnolence 7.5%
Tardive Dyskinesia 7.5%
Adverse Drug Reaction 5.0%
Convulsion 5.0%
Medication Error 5.0%
Treatment Noncompliance 5.0%
Tremor 5.0%
Weight Increased 5.0%
Wrong Drug Administered 5.0%
Adverse Event 2.5%
Blood Glucose Increased 2.5%
Completed Suicide 2.5%
Condition Aggravated 2.5%
Drug Hypersensitivity 2.5%
Drug Ineffective 2.5%
Dyskinesia 2.5%
Excessive Eye Blinking 2.5%
Concomitant
Schizophrenia 22.3%
Bipolar Disorder 8.8%
Depression 8.3%
Product Used For Unknown Indication 7.8%
Drug Use For Unknown Indication 5.6%
Psychotic Disorder 5.3%
Schizoaffective Disorder 4.8%
Asthma 4.5%
Smoking Cessation Therapy 4.5%
Anxiety 4.3%
Sleep Disorder 4.3%
Hypertension 3.7%
Schizophrenia, Paranoid Type 3.0%
Agitation 2.5%
Diabetes Mellitus 2.3%
Insomnia 2.3%
Affective Disorder 1.7%
Pain 1.7%
Hyperlipidaemia 1.2%
Non-small Cell Lung Cancer 1.2%
Weight Increased 17.6%
Type 2 Diabetes Mellitus 15.4%
Somnolence 7.4%
Drug Ineffective 6.6%
Pneumonia 4.4%
Tremor 4.4%
Psychotic Disorder 3.7%
Tardive Dyskinesia 3.7%
Type 1 Diabetes Mellitus 3.7%
Vaginal Infection 3.7%
Weight Decreased 3.7%
Death 2.9%
Diabetes Mellitus 2.9%
Hypertension 2.9%
Lung Neoplasm Malignant 2.9%
Overdose 2.9%
Prescribed Overdose 2.9%
Schizophrenia 2.9%
Vomiting 2.9%
Aggression 2.2%